Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Horizon Discovery Group announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines.
read more
Vetter has invested in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.
read more
Lonza announced the establishment of a Center of Excellence for Dry Powder Inhaler drug product development at its OR site.
read more
Bionova Scientific has initiated construction of its new biologics manufacturing facility.
read more
Bellwyck has announced the completion of the company’s three-pronged strategic press-acquisition initiative.
read more
Sorrel Medical announced the opening of a new manufacturing facility with state-of-the-art cleanroom facilities to accommodate manufacturing scalability of its wearable drug delivery devices.
read more
OpSec Security has announced a COVID-19 testing kit authentication and traceability solution.
read more
Omya has rebuilt and expanded its calcium carbonate production plant in Orgon, France, creating a substantially higher capacity for its functionalized calcium carbonate product platform, a new packaging line and an on-site warehouse.
read more
Lipidor announced an agreement with Cadila Pharmaceuticals to conduct a Phase III study for Lipidor's drug candidate AKP-02.
read more
Turning Point Therapeutics and Zai Lab announced an exclusive license agreement for the development and commercialization of Turning Point’s lead drug candidate, repotrectinib, in Greater China, which includes mainland China, Hong Kong, Macau and ...
read more
Eremid Research Services has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization - DHMRI.
read more
Mission has raised $15m in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer.
read more
Anixa Biosciences and OntoChem have completed the initial in silico screening process of their drug discovery program and have identified an additional specific compound, as well as multiple analogs, that could function as inhibitors of the main ...
read more
The FDA is alerting clinical laboratory staff and health care providers of an increased risk of a false positive result with BD SARS-CoV-2 Reagents for the BD Max System test.
read more
Vetter and Rentschler Biopharma have announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
read more